The HPV vaccine can prevent more than 31,000 cancer cases a year. This is why I care so much.
Robin Mutz, chief nurse executive at St. Jude, has nearly 40 years’ experience in nursing and shares her story about why the HPV vaccine is so important.
One of my dear friends recently passed away because of treatment-related complications of stage 4 cervical cancer.
When her husband called me with the news, I knew what that meant. Every year in the United States, the human papillomavirus (HPV) causes 33,700 cancers in men and women. The HPV vaccine can prevent most of the cancers (about 31,200) from ever developing. Here’s are 5 things to know about HPV and cancer.
- The Centers for Disease Control and Prevention (CDC) recommends the HPV vaccine for boys and girls.
- HPV vaccination can be started as early as age 9, but is typically initiated at the adolescent check-up with other immunizations.
- Vaccination is also recommended for girls aged 13 through 26 years and boys aged 13 through 21 years who have not yet been fully vaccinated.
- More than 31,000 cases of cancer could be prevented with HPV vaccination each year. Getting vaccinated early protects children long before they’re exposed to HPV.
- While the HPV vaccine works best with adolescents, the FDA recently expanded its approval for use in males and females aged 27-45 who haven’t received the vaccine.
My dear friend never had the opportunity to receive the vaccine. When her son went to his physician to get the HPV vaccine, his doctor told him the vaccine was only for girls.
There is so much misinformation about HPV and the vaccine. As health care providers, we are obligated to educate our communities, health care providers, third party payors and legislators. Everyone should have the opportunity of many more reunion weekends, not have life halted from something that was preventable. We must stop HPV-related cancers. It’s preventable.
Related Posts
Recent Posts
St. Jude mentors nurture tomorrow’s scientists
| Nov 30, 2023Mentorship has tremendous value for the mentor as well as the mente
Learn moreWhy are we still studying COVID-19?
| Nov 28, 2023Learn about the driving forces behind ongoing COVID-19 research
Learn moreThere from the beginning: The evolution of HIV research and care at St. Jude
| Nov 21, 2023Research and care for HIV has shifted over time, but St. Jude has always been at the forefront.
Learn more5 Questions for Jason Rosch, PhD
| Nov 14, 2023Learn what inspired Jason Rosch, PhD, to a career in science studying host-pathogen interactions.
Learn morePulling the curtain back on the RSV window of vulnerability
| Nov 14, 2023Researchers look to mothers for solution to RSV
Learn moreABOUT US
Sharing stories of the people, projects and progress being fueled by scientific advances at St. Jude Children’s Research Hospital.